Both in Pharmaceuticals
Fulcrum Therapeutics vs Larimar Therapeutics
Over the past year FULC returned −59.4% and LRMR returned −52.7%; their daily moves had a correlation of 0.17.
FULC −59.4% LRMR −52.7%Growth of $1, one year, split-adjusted
| Metric | FULC | LRMR |
|---|---|---|
| Price | $3.65 | $1.99 |
| Market cap | $278.8M | $206.2M |
| Today | −0.55% | −0.25% |
| 1 month | −3.2% | −47.8% |
| 6 months | −56.0% | −58.6% |
| Year to date | −67.7% | −47.9% |
| 1 year | −62.1% | −53.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $318.8M | $156.3M |
| Dividend yield | — | — |
| Volatility (60d) | 21.4% | 65.2% |
| Short % of float | 11.1% | 24.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).